CEO Blog - Why global harmonisation of medical device nomenclature matters
25 May 2023
CEO Blog by Deniz Bruce
As the CEO of the Global Medical Device Nomenclature (GMDN) Agency, I want to talk about the importance of global harmonisation of medical device nomenclature and why the GMDN is best placed to be adopted globally.
Medical devices are an essential component of modern healthcare systems, and their impact on patient care is significant. However, the diverse range of medical devices available on the market has led to significant variations in nomenclature, creating confusion and making it difficult to ensure consistency and safety in their use.
To address this issue, the GMDN was created to provide a single, internationally recognised nomenclature for medical devices. The GMDN currently has more than 15,000 active members in more than 145 countries globally.
It is also used by medical device Regulators in more than 70 countries worldwide, making it the most widely used and trusted medical device nomenclature in the world.
At the GMDN Agency, we firmly believe that global harmonisation of medical device nomenclature is essential to ensuring patient safety, improving regulatory compliance, and fostering innovation. A globally harmonised nomenclature system can help facilitate better communication between stakeholders and make it easier to track and monitor medical devices throughout their lifecycle.
The GMDN is the best-placed nomenclature system to be adopted globally because of its proven track record of success. We have been developing and maintaining the GMDN for over 20 years, and our system has been adopted by regulators and healthcare providers worldwide. Our system is also continuously updated to reflect the latest advances in medical technology.
In addition, the GMDN is designed to be flexible and adaptable, supporting organisations operating in multiple jurisdictions, by simplifying regulatory compliance and streamlining supply chain management.
Throughout 2023-2024 we will continue to launch new analytical tools and services as part of our commitment to meet the evolving needs of stakeholders and stay relevant in an ever-changing industry.
In conclusion, the importance of global harmonisation of medical device nomenclature cannot be overstated. It is critical to ensuring patient safety, improving regulatory compliance, and fostering innovation in the medical device industry.
Deniz Bruce CEO, GMDN Agency